C07F7/0807

COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE

A composition for an organic optoelectronic device, an organic optoelectronic device, and a display device, the composition including a first compound represented by Chemical Formula 1 and a second compound represented by Chemical Formula 2,

##STR00001##

ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES
20210395276 · 2021-12-23 · ·

Provided are spiro-bisilepine compounds. Also provided are formulations comprising these spiro-bisilepine compounds. Further provided are OLEDs and related consumer products that utilize these spiro-bisilepine compounds.

COMPOUNDS THAT CAN BE USED IN AN ORGANIC ELECTRONIC DEVICE AS ACTIVE COMPOUNDS
20210384443 · 2021-12-09 ·

The invention relates to compounds that can be used in an organic electronic device as an active compound, in particular for use in electronic devices. The invention further relates to a method for producing the compounds according to the invention, and to electronic devices comprising same.

SILIRANE-FUNCTIONALISED COMPOUNDS, IN PARTICULAR ORGANOSILICON COMPOUNDS, FOR PREPARING SILOXANES

A silirane-functionalized compound, a process for preparing the same, and a process for preparing siloxanes using a silirane-functionalized compound are described herein.

Dibenzo[d,B]silole-based reactive mesogens
11316118 · 2022-04-26 · ·

A compound of Formula (I)
D-S.sup.1-A-S.sup.2—B.sup.1,  Formula (I) wherein: A represents a conjugated chain of from 1 to 20 aromatic moieties independently selected from the group consisting of aromatic moieties, heteroaromatic moieties and E moieties, provided that A includes at least one E moiety, wherein E is selected from the group consisting of: E.sup.1 being a dibenzo[d,b]silole moiety of the structure: ##STR00001## E.sup.2 being a moiety of the structure: ##STR00002## and E.sup.3 being a moiety of the structure: ##STR00003## wherein E is connected in the conjugated chain of A and optionally to S.sup.1 or to S.sup.2 through covalent bonds at Y and Z; wherein each R is independently selected from the group consisting of straight chain or branched C.sub.1-C.sub.20 alkyl and C.sub.2-C.sub.20 alkenyl, optionally wherein from 1 to 5 CH.sub.2 groups are each replaced by an oxygen, provided that no acetal, ketal, peroxide or vinyl ether is present in the R group, and optionally wherein each H bonded to a C in each R group may independently be replaced by a halogen; wherein the X moieties are the same and are selected from the group consisting of hydrogen, straight chain or branched C.sub.1-C.sub.8 alkyl, straight chain or branched C.sub.1-C.sub.8 alkoxyl and a halogen, wherein each E moiety may have the same or different X moieties, wherein W is either an oxygen or sulfur atom, D represents a moiety having one or more cross-linkable functionalities, S.sup.1 and S.sup.2 are flexible linker groups; and B.sup.1 represents a moiety having one or more cross-linkable functionalities or a hydrogen atom, with the proviso that when B.sup.1 represents a hydrogen atom, D represents a moiety having at least two cross-linkable functionalities.

Adhesive composition, covering substrate, and cured product

The adhesive composition includes: a cyclic organosilazane compound of the following general formula (1): ##STR00001##
wherein R.sup.1s each independently represent a substituted or unsubstituted monovalent hydrocarbon group having 1 to 10 carbon atoms, and p represents an integer of 3 to 8; and a hydrolyzable group-containing organosilicon compound containing an alkoxysilane compound of the following general formula (2) and/or a partial hydrolytic condensate thereof:
R.sup.2.sub.x—Si(OR.sup.3).sub.4-x   (2)
wherein R.sup.2 represents an unsubstituted monovalent hydrocarbon group having 1 to 10 carbon atoms and optionally having an oxygen atom, R.sup.3 represents an unsubstituted monovalent hydrocarbon group having 1 to 10 carbon atoms, and x represents an integer of 0 to 2.

PHOTOLUMINESCENT LUBRICATING GREASE COMPOSITION, PHOTOLUMINESCENT MATERIAL AND THE PREPARATION METHODS THEREOF
20210355409 · 2021-11-18 ·

A silole derivative is of formula (I):

##STR00001## each of the groups in the above formula is defined as those in the description. The silole derivative of formula (I) has aggregation-induced emission performance, and is particularly applicable in luminescent parts and devices, fluorescent probes, biological imaging, lubricating oils and greases. A lubricating grease composition has photoluminescence performance, as well as one or more of advantageous anti-oxidation properties, anti-wear properties, extreme pressure properties and anti-rust properties. It is applicable in many mechanical equipment in electrical industry, metallurgical industry, food industry, paper industry, automobile industry and aircraft industry.

ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE USING SAME

An organic electroluminescence device comprising: a cathode, an anode, and an organic layer disposed between the cathode and the anode, wherein the organic layer comprises a compound represented by the following formula (1), and a compound A having a Stokes shift of 20 nm or smaller and an emission peak wavelength of 440 nm to 465 nm (at least one of Ar.sub.1 and Ar.sub.2 is a monovalent group having a structure represented by the following formula (2)).

##STR00001##

NOVEL COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME, AND ELECTRONIC APPARATUS

A compound represented by the following formula (1), wherein in the formula, L.sub.1 and L.sub.2 are predetermined linking groups, and Ar.sub.1 is a monovalent group having a structure represented by the following formula (2).

##STR00001##

Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator

This disclosure provides modulators of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), pharmaceutical compositions containing at least one such modulator, methods of treatment of cystic fibrosis by administering such modulators and pharmaceutical compositions, and processes for making such modulators.